Wordt geladen...
Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
The safety and efficacy of the use of collagenase Clostridium histolyticum (CCH) for the treatment of Peyronie’s disease has been confirmed over the past several years. However, identification of the ideal patient population for use of this treatment is not well established. Multiple studies have at...
Bewaard in:
| Gepubliceerd in: | Patient Prefer Adherence |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338950/ https://ncbi.nlm.nih.gov/pubmed/28280315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S113507 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|